跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Ildecef
Approved
STANDARD
Ildecef
BCWorld Pharm. Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b543f871d817e5c2
Company
BCWorld Pharm. Co., Ltd.
Type
Standard
Approval Details
Approval Id
b543f871d817e5c2
Drug Approval Philippines Name
Ildecef
Product Name
Ildecef
Registration Number
DRP-7635-02
Brand Name
Ildecef
Generic Name
Ranitidine (as hydrochloride)
Dosage Form
Solution For Injection (IM/IV)
Dosage Strength
25 mg/mL (50 mg/2 mL)
Manufacturer
BCWorld Pharm. Co., Ltd.
Importer
Euro-Health Care Exponents, Inc.
Distributor
Medirich Pharma Distribution Corp.
Issuance Date
28 November 2023
Expiry Date
14 November 2028
Pharmacologic Category
H2-Receptor Antagonist
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b543f871d817e5c2
Type
Standard
Back to Philippines FDA Approvals
Ildecef - Philippines FDA Drug Approval Details